The biotech sector is experiencing a correction after a pandemic-driven surge, with venture capital focusing on mature companies and M&A activity expected to rise amid regulatory changes. Innovation thrives, particularly in targeted therapies like antibody-drug conjugates and radioligand therapy, as cancer centers adapt to new treatments. Despite challenges, the industry's future appears optimistic, driven by equity capital markets and technological advancements.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.